A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy.
about
Severe airway epithelial injury, aberrant repair and bronchiolitis obliterans develops after diacetyl instillation in ratsOverview of clinical lung transplantationCirculating fibrocytes correlate with bronchiolitis obliterans syndrome development after lung transplantation: a novel clinical biomarker.MMP-8 promotes polymorphonuclear cell migration through collagen barriers in obliterative bronchiolitisMesenchymal stem cell pretreatment of non-heart-beating-donors in experimental lung transplantation.Regional differences in susceptibiity of bronchial epithelium to mesenchymal transition and inhibition by the macrolide antibiotic azithromycin.Mechanistic differences between phenotypes of chronic lung allograft dysfunction after lung transplantation.A randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation.Thin-section computed tomography findings before and after azithromycin treatment of neutrophilic reversible lung allograft dysfunctionPathogen- and host-directed anti-inflammatory activities of macrolide antibioticsLongitudinal analysis of the lung microbiome in lung transplantationBronchiolitis obliterans syndrome: the Achilles' heel of lung transplantation.Bronchoalveolar lavage as a tool to predict, diagnose and understand bronchiolitis obliterans syndrome.Macrolide antibiotics and the airway: antibiotic or non-antibiotic effects?Innate and adaptive interleukin-17-producing lymphocytes in chronic inflammatory lung disorders.Lung transplantation: infection, inflammation, and the microbiome.Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD.Bronchiolitis obliterans after allo-SCT: clinical criteria and treatment options.Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases.Chronic lung allograft dysfunction after lung transplantation: the moving target.Role of genetics in lung transplant complications.Current views on chronic rejection after lung transplantation.Short-Term Variation of Lung Function and Airway Inflammation in Children and Adolescents with Bronchiolitis Obliterans.Airway remodelling in the transplanted lung.Zonal organ allocation system and its impact on long-term outcomes after lung transplantation: a propensity score matched analysis†.Prophylactic Azithromycin Therapy After Lung Transplantation: Post hoc Analysis of a Randomized Controlled Trial.Chronic lung allograft dysfunction phenotypes and treatment.Update on Chronic Lung Allograft Dysfunction.Azithromycin reduces pulmonary fibrosis in a bleomycin mouse model.The macrolide clarithromycin inhibits experimental post-transplant bronchiolitis obliterans.Prevention of chronic rejection after lung transplantation.Interleukin-1α induced release of interleukin-8 by human bronchial epithelial cells in vitro: assessing mechanisms and possible treatment options.BALF cytokines in different phenotypes of chronic lung allograft dysfunction in lung transplant patients.Are the antimicrobial properties of macrolides required for their therapeutic efficacy in chronic neutrophilic airway diseases?Macrolides for macrophages in chronic obstructive pulmonary disease.Insights from the European Respiratory Society 2018 Annual International Congress in the fields of thoracic surgery and lung transplantation
P2860
Q28387202-302F3255-6133-406A-A76D-F46815EA845DQ28661021-06D590C8-56EC-499B-B5C9-478E43135D6CQ30425688-B2C8380F-392A-4187-A6BD-0F072DCF328EQ33571189-242E35A1-46E3-4F0E-AD16-DBD544521475Q34216196-028F7907-BB09-4CF5-9F27-C9F98D504985Q34533624-74023023-9FE1-4C7B-983E-018B8C908619Q34803336-F5D69EDE-92A8-496B-9377-6C690D243D3DQ35550826-38368D4B-8DA3-4B5A-9243-89ED6A944D99Q35552590-FA5152D8-192B-4C67-83D2-68D544F23BD0Q36072425-61B51886-402C-481E-AADE-1ED7B2A6C4D2Q36536569-7EDFBEB6-505E-47F7-8512-CD246CB2602AQ36623201-7AB78A0A-06A9-4CB5-BAF3-99F98019F99CQ36640114-ECA52367-E91B-4E72-A008-6709225BF03AQ37691452-9112481D-5C1D-4741-9585-062D68138BF2Q37811625-6EF23F64-2C1B-4DE7-9A02-6AE1EB6A259CQ37832677-E7AA1D9F-BC56-4A07-B418-8C1950AF275CQ37858415-B9A9DA34-5A9D-4DED-B4DF-D1194FBC5B0DQ37923305-B3E8074B-B1DD-44F9-9E26-2DB5FFFD8573Q37959271-72D7EA7E-578D-402F-AB18-B05973370AB9Q38058746-450E20CC-BCDA-4A41-A32C-8B78AAB090BCQ38376217-578FC8D9-4DF0-480B-AEEA-B3D654BAFB47Q38413323-E17767BE-6D80-4F31-A355-8634F9221116Q38850519-95669924-F2C3-4A73-9A13-CE88B4FCEEFDQ39006011-01A4D964-A260-45AE-BC51-403FEDD81373Q40557622-0D08BC8D-3DA6-4881-8707-2C6421769503Q40998457-7C7A6D17-F191-46CD-8A4C-8CA0381E4886Q41303108-C00AE266-0C09-48AC-8FC7-E476B0FD0310Q41975571-C8A515F8-43AF-4289-A9E3-5267DCF5E115Q42875432-F47F7E06-2193-48EA-9F02-4DE3D14229F1Q43227521-B405F0FA-50CD-4516-9DA0-3FEFC8FF8EB1Q47662940-19D7507F-72E9-4CC2-AAAF-3DC04441F177Q48000057-510AB6A2-9CDE-4F98-A817-57B637F2187DQ48122419-D97B67B7-761A-4242-B51B-BC5114FE8D51Q49147142-BF2C038A-4205-44BD-A644-A27C5AAA8655Q54337018-015DE90C-1E69-4532-86DC-5E4AAAB4E0B0Q57494707-D08110E2-05E6-4F54-977F-690889A06623
P2860
A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A dichotomy in bronchiolitis o ...... ealed by azithromycin therapy.
@en
A dichotomy in bronchiolitis o ...... ealed by azithromycin therapy.
@nl
type
label
A dichotomy in bronchiolitis o ...... ealed by azithromycin therapy.
@en
A dichotomy in bronchiolitis o ...... ealed by azithromycin therapy.
@nl
prefLabel
A dichotomy in bronchiolitis o ...... ealed by azithromycin therapy.
@en
A dichotomy in bronchiolitis o ...... ealed by azithromycin therapy.
@nl
P2093
P921
P1476
A dichotomy in bronchiolitis o ...... ealed by azithromycin therapy.
@en
P2093
B M Vanaudenaerde
D E Van Raemdonck
E K Verbeken
G M Verleden
L J Dupont
W De Wever
P304
P356
10.1183/09031936.00134307
P577
2008-10-01T00:00:00Z